| Particle-Based therapies for antigen specific treatment of type 1 diabetes NR Lukesh, DD Middleton, EM Bachelder, KM Ainslie International journal of pharmaceutics 631, 122500, 2023 | 8 | 2023 |
| Enhancement of subunit vaccine delivery with zinc-carnosine coordination polymer through the addition of mannan JA Roque III, NR Lukesh, DA Hendy, TA Dixon, MJ Islam, ... International Journal of Pharmaceutics 656, 124076, 2024 | 3 | 2024 |
| Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations DA Hendy, ES Pena, L Ontiveros‐Padilla, TA Dixon, DD Middleton, ... Bioengineering & Translational Medicine 9 (2), e10634, 2024 | 3 | 2024 |
| Microparticles incorporating dual apoptotic factors to inhibit inflammatory effects in macrophages SR Simpson, DD Middleton, NR Lukesh, MJ Islam, SA Ehrenzeller, ... Journal of Pharmaceutical Sciences 113 (11), 3196-3205, 2024 | 1 | 2024 |
| Comparison of emulsion and spray methods for fabrication of rapamycin-loaded acetalated dextran microparticles SA Ehrenzeller, NR Lukesh, RT Stiepel, DD Middleton, SM Nuzzolo, ... RSC pharmaceutics 1 (4), 727-741, 2024 | 1 | 2024 |
| Induction of Antigen-Specific Tolerance in a Multiple Sclerosis Model without Broad Immunosuppression RT Stiepel, SR Simpson, NR Lukesh, DD Middleton, DA Hendy, ... ACS nano, 2025 | | 2025 |
